Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020.
3 contributing indexes 4 score components composite score.
Canonical asset packet first: fundamentals, macro index exposure, entry value, and active narrative alignment. Driver rows link back to the public index that moved the score.
| Index | Driver | Reason | Weight | Condition | Contribution | As Of |
|---|---|---|---|---|---|---|
| BPHI | Biotech & Pharma Health Index | mrna platform innovation | 18% | mrna platform innovation — tailwind Near normal—/100Tailwind +0.13σ | +0.033 | 2026-05-22 |
| RACI | Robotics & Automation Capex Index | research activity | 5% | research activity — tailwind Moderate signal—/100Tailwind +0.53σ | +0.030 | 2026-05-22 |
| RQRI | Risk-Quality Rotation Index | risk appetite | 3% | risk appetite — tailwind Moderate signal—/100Tailwind +1.30σ | +0.028 | 2026-05-22 |
